Internal Medicine, Hematology & Oncology · Phoenix, AZ
NPI
1851323547
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
925 E McDowell Rd
Phoenix, AZ, 85006
Phone (602) 521-3700
Groups this clinician bills Medicare through
Medicare paid, 2024
$48K
734 services
Medicare patients, 2024
334
Average age 75
Drug cost, 2024
$4.2M
1,437 prescriptions
Company payments, 2025
$51.42
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David M Paul was code 99214 (office e&m - established), 310 times for 142 patients. In total David M Paul billed 734 services in 9 codes, and Medicare paid $48K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-07-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 310 | 142 | $68.91 | $21K |
| 99213 Office E&M - Established | Facility | 280 | 183 | $41.93 | $12K |
| 99204 Office E&M - New | Facility | 47 | 47 | $90.75 | $4,265 |
| 99215 Office E&M - Established | Facility | 45 | 32 | $108.33 | $4,875 |
| 99205 Office E&M - New | Facility | 37 | 37 | $130.86 | $4,842 |
By year: 2022 $43K for 785 services; 2023 $47K for 751 services; 2024 $48K for 734 services.
Medicare prescription drug claims, 2024
In 2024, the drug David M Paul prescribed most often to Medicare patients was Anastrozole, with 371 prescriptions and refills. In total David M Paul wrote 1,437 Medicare prescriptions that cost $4.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 371 | 1,045 | 116 | $7,405 |
| Letrozole Generic | 72 | 206 | 26 | $2,509 |
| Ondansetron Hcl Generic | 49 | 49 | 23 | $193 |
| Gabapentin Generic | 45 | 87 | 13 | $515 |
| Imbruvica Ibrutinib | 42 | 48 | Under 11 | $670K |
| Hydroxyurea Generic | 39 | 112 | 12 | $1,109 |
| Tamoxifen Citrate Generic | 35 | 97 | Under 11 | $978 |
| Prednisone Generic | 34 | 44 | Under 11 | $183 |
| Exemestane Generic | 31 | 72 | Under 11 | $4,264 |
| Imatinib Mesylate Generic | 31 | 39 | Under 11 | $9,239 |
| Jakafi Ruxolitinib Phosphate | 29 | 29 | Under 11 | $497K |
| Morphine Sulfate Er Morphine Sulfate | 28 | 28 | Under 11 | $484 |
| Oxycodone Hcl Generic | 27 | 27 | Under 11 | $249 |
| Acyclovir Generic | 27 | 44 | Under 11 | $253 |
| Abiraterone Acetate Generic | 25 | 25 | Under 11 | $110K |
Brand drugs: 358 claims; generic drugs: 1,079 claims; opioid claims: 68.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David M Paul $51.42 ($51.42 in general payments such as food, travel and fees) from 2 companies. The largest payer was Jazz Pharmaceuticals Inc. with $27.18.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.